How Does Berry Global Group Company Reach Customers and Turn Demand into Sales?

Berry Global Group targets Tier 1 and Tier 2 global CPG companies and pharmaceutical manufacturers because these buyers demand scalable, validated packaging that protects product and complies with regulation. Selling to procurement, R&D heads, and Chief Sustainability Officers lets Berry Global Group marketing strategy and Berry Global sales strategy focus on technical specs and sustainability performance to close large-volume contracts.

Beauty, personal care, and healthcare brands are prioritized because packaging performance directly drives consumer preference and safety; these accounts often require custom, multi-material solutions and quicker innovation cycles. Berry Global customer acquisition emphasizes technical pilots, co-development, and trials to convert product fit into repeat orders.

Berry Global Group positions itself as a technical, scale-capable partner offering barrier films, rigid and flexible packaging, and engineered solutions with post-consumer recycled (PCR) content to meet 2030 mandates. This market stance supports Berry Global direct sales to consumer goods brands and Berry Global omnichannel distribution strategy for packaging across channels.

Brands increasingly buy on decarbonization and PCR content: as of 2025, customers requiring PCR rose sharply, and Berry Global's public disclosures show investments in recycling and advanced resins to capture that demand. The combination of validated performance, regulatory compliance, and sustainability messaging driving sales for Berry Global products shortens purchase cycles and increases wallet share with large customers.

Berry Global Group marketing strategy centers on direct B2B sales to consumer goods brands and contract manufacturing agreements; it also uses distributor channels and selective retail partnerships to cover multiple end markets.

Pricing relies on long-term contracts with resin pass-through mechanisms that protect margins and on higher-priced sustainable packaging solutions that command premium fees and longer contract terms.

Sales conversion is supported by offering both containers and specialized closures, reducing customer switching (share of wallet increases) and by B2B account management, trade shows, and technical sales that prove manufacturing fit.

In 2025, a majority of revenue came from products where Berry Global Group, Inc. holds a top-three market position, supporting recurring orders; upselling to sustainable alternatives increased ASPs and produced stickier contracts and customer expansion.

Berry Global Group marketing strategy now emphasizes healthcare closures and specialty films, which historically carry higher ASPs and margins; this mix shift underpins projected EBITDA margins near 16 percent to 18 percent and improves pricing power for packaging solutions sales.

Berry Global sales strategy blends direct B2B account management with distributor networks and selective digital outreach; distribution channels for Berry Global and trade show and event sales strategy remain important for converting leads into contracts, while e-commerce and online ordering support repeat orders for standardized SKUs.

Major risks include raw material and resin price volatility (which can compress margins), weaker consumer packaged goods demand that limits North American volume growth (~2 percent forecast), and integration or execution delays in new film and circular polymer lines that could slow Berry Global customer acquisition.

Outlook is stable to positive: disciplined pricing strategy, a leaner asset base after divestitures, and planned focus on high-margin verticals should sustain free cash flow and maintain leverage near 2.5x – 3.0x; still, growth will be measured and contingent on resin markets and end-user demand.